Venture Capital

Sera Prognostics Completes $100M Series E Financing

by vcaonline.com posted 4months ago 34 views
- Several prominent healthcare-focused institutional investors fund Sera to expand commercialization of the PreTRM® Test - SALT LAKE CITY, April 28, 2021-- Sera Prognostics, Inc., The Pregnancy Company® (“Sera”), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the completion of a $100 million Series E financing. Several leading healthcare-focused institutional investors have joined this financing round, including Vivo Capital, aMoon Fund, Parian Global, and others, led by existing investors Anthem, Inc., and Blue Ox Healthcare Partners.

In this article